Takuya Fukazawa

Okayama, 7008505, Japan

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 48 publications

Establishment and functional characterization of an EGFR-amplified tumoroid from squamous cell carcinoma of unknown primary.

Establishment and functional characterization of an EGFR-amplified tumoroid from squamous cell carcinoma of unknown primary.

Journal: Human cell
Published: March 23, 2026

Therapeutic pCRISPRi Delivery to Lung Squamous Cell Carcinoma by Combining Nanobubbles and Ultrasound.

Therapeutic pCRISPRi Delivery to Lung Squamous Cell Carcinoma by Combining Nanobubbles and Ultrasound.

Journal: Pharmaceutics
Published: July 18, 2025

Establishment and characterization of novel patient-derived esophageal tumoroids with long-term cultivability.

Establishment and characterization of novel patient-derived esophageal tumoroids with long-term cultivability.

Journal: Human cell
Published: December 22, 2024

Correction: Inhibition of the Growth Factor MDK/Midkine by a Novel Small Molecule Compound to Treat Non-Small Cell Lung Cancer.

Correction: Inhibition of the Growth Factor MDK/Midkine by a Novel Small Molecule Compound to Treat Non-Small Cell Lung Cancer.

Journal: PloS one
Published: July 09, 2024

Patho-transcriptomic analysis of invasive mucinous adenocarcinoma of the lung (IMA): comparison with lung adenocarcinoma with signet ring cell features (SRCC).

Patho-transcriptomic analysis of invasive mucinous adenocarcinoma of the lung (IMA): comparison with lung adenocarcinoma with signet ring cell features (SRCC).

Journal: bioRxiv : the preprint server for biology
Published: July 01, 2024

Transforming tumoroids derived from ALK-positive pulmonary adenocarcinoma to squamous cell carcinoma in vivo.

Transforming tumoroids derived from ALK-positive pulmonary adenocarcinoma to squamous cell carcinoma in vivo.

Journal: Human cell
Published: April 08, 2024

A novel molecular target, superoxide dismutase 1, in ALK inhibitor-resistant lung cancer cells, detected through proteomic analysis.

A novel molecular target, superoxide dismutase 1, in ALK inhibitor-resistant lung cancer cells, detected through proteomic analysis.

Journal: Experimental cell research
Published: March 30, 2024

The combined inhibition of SLC1A3 and glutaminase in osimertinib-resistant EGFR mutant cells.

The combined inhibition of SLC1A3 and glutaminase in osimertinib-resistant EGFR mutant cells.

Journal: Biochimica et biophysica acta. General subjects
Published: February 19, 2024

Establishment and characterization of novel high mucus-producing lung tumoroids derived from a patient with pulmonary solid adenocarcinoma.

Establishment and characterization of novel high mucus-producing lung tumoroids derived from a patient with pulmonary solid adenocarcinoma.

Journal: Human cell
Published: January 12, 2024

Patient-derived tumoroid models of pulmonary large-cell neuroendocrine carcinoma: a promising tool for personalized medicine and developing novel therapeutic strategies.

Patient-derived tumoroid models of pulmonary large-cell neuroendocrine carcinoma: a promising tool for personalized medicine and developing novel therapeutic strategies.

Journal: Cancer letters
Published: November 19, 2023

A surgical case of pulmonary adenocarcinoma in the right upper lobe associated with a systemic artery-to-pulmonary artery fistula.

A surgical case of pulmonary adenocarcinoma in the right upper lobe associated with a systemic artery-to-pulmonary artery fistula.

Journal: Thoracic cancer
Published: April 05, 2023

The complexity of EGFR exon 19 deletion and L858R mutant cells as assessed by proteomics, transcriptomics, and metabolomics.

The complexity of EGFR exon 19 deletion and L858R mutant cells as assessed by proteomics, transcriptomics, and metabolomics.

Journal: Experimental cell research
Published: October 06, 2022
Showing 1-12 of 48

Last Updated: 09/26/2026